Guofeng Cheng Selected Research

Hepatitis C

7/2012

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guofeng Cheng Research Topics

Disease

25	Infections 01/2022 - 02/2005
15	Schistosomiasis (Bilharziasis) 01/2022 - 03/2010
5	Virus Diseases (Viral Diseases) 02/2008 - 09/2003
4	Schistosomiasis japonica 01/2022 - 04/2015
4	Neoplasms (Cancer) 01/2021 - 12/2013
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2019
1	Fibrosis (Cirrhosis) 08/2021
1	Hyperplasia 08/2021
1	Inflammation (Inflammations) 08/2021
1	Opisthorchiasis 08/2021
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	Chronic Hepatitis C 01/2016
1	Reinfection 11/2014
1	Parasitic Diseases (Parasitic Disease) 11/2014
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2014
1	Diarrhea 01/2014
1	Pathologic Processes 01/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2012
1	Starvation 12/2012
1	Hepatitis C 07/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2008
1	Insulinoma 11/2008
1	Hepatocellular Carcinoma (Hepatoma) 05/2007

Drug/Important Bio-Agent (IBA)

10	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2007
10	Antiviral Agents (Antivirals)IBA 05/2014 - 06/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
6	Pharmaceutical PreparationsIBA 08/2021 - 03/2010
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
4	ledipasvirIBA 01/2016 - 07/2012
3	Peptides (Polypeptides)IBA 01/2021 - 02/2008
3	CytokinesIBA 01/2017 - 11/2008
3	InterferonsIBA 01/2017 - 10/2007
3	VaccinesIBA 11/2014 - 06/2005
2	LipidsIBA 08/2021 - 02/2008
2	Nucleic AcidsIBA 01/2020 - 05/2007
2	SofosbuvirIBA 01/2019 - 01/2016
2	velpatasvirIBA 01/2019 - 01/2019
2	Caspase 3 (Caspase-3)IBA 04/2015 - 11/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 05/2011
1	GlycogenIBA 08/2021
1	AnthelminticsIBA 08/2021
1	AntioxidantsIBA 08/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2021
1	Praziquantel (Biltricide)FDA Link 08/2021
1	Messenger RNA (mRNA)IBA 08/2021
1	Spider Venoms (Venom, Spider)IBA 01/2021
1	GoldIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 12/2020
1	UbiquitinIBA 12/2020
1	Recombinases (Recombinase)IBA 01/2020
1	EpitopesIBA 01/2020
1	HCV NS3-4A Protease InhibitorsIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	TabletsIBA 01/2019
1	Recombinant ProteinsIBA 11/2018
1	GS-9256IBA 01/2017
1	hepatitis B virus X proteinIBA 01/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2016
1	GS-6620IBA 01/2014
1	Pattern Recognition ReceptorsIBA 01/2014
1	GS-9451IBA 01/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014
1	PhosphoproteinsIBA 02/2013
1	Inhibitor of Apoptosis ProteinsIBA 12/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012
1	Peptide LibraryIBA 11/2011
1	Biological ProductsIBA 03/2010
1	Complementary DNA (cDNA)IBA 03/2010
1	cyclophilin BIBA 03/2010
1	Streptozocin (Streptozotocin)FDA Link 11/2008
1	adefovirIBA 01/2008
1	NucleotidesIBA 01/2008
1	Lamivudine (Epivir)FDA Link 01/2008
1	Small Interfering RNA (siRNA)IBA 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 05/2007
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2007
1	Phosphotransferases (Kinase)IBA 02/2005
1	Peptide Initiation Factors (Initiation Factor)IBA 02/2005
1	Double-Stranded RNA (RNA, Double Stranded)IBA 02/2005
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 02/2005
1	eIF-2 Kinase (eIF 2 Kinase)IBA 02/2005

Therapy/Procedure

4	Therapeutics 08/2021 - 01/2008
1	Drug Therapy (Chemotherapy) 11/2014
1	Transplantation 11/2008
1	RNAi Therapeutics 01/2008